Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 13 Uterine Cervical Neoplasms 4 Ovarian Neoplasms 3 Vulvar Neoplasms 2 Squamous Intraepithelial Lesions 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Breast Neoplasms 2 Anus Neoplasms 2 Acquired Immunodeficiency Syndrome 2 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Sezary Syndrome 1 Pseudomyxoma Peritonei 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 niraparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × Observation × Gynecologic × Clear all

NCT05775549 2024-09-20

FLAME

AstraZeneca

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡